Blauwet Elected to US Anti-Doping Agency Board of Directors

Retired U.S Paralympian Cheri Blauwet, a member of the International Paralympic Committee (IPC) Medical Committee, has been elected to the U.S Anti-Doping Agency Board of Directors. 02 Oct 2012
Imagen
London 2012 unveil Anti-Doping Laboratory.

London 2012 unveil Anti-Doping Laboratory.

ⒸGetty Images
By IPC

“Not only is this great news for her but the whole Paralympic Movement, as it underlines our growing profile in world sport.”

Blauwet is a three-time Paralympian having competed in Games in Sydney, Athens and Beijing - picking up seven Paralympic medals along the way in wheelchair racing.

She is also a two-time winner of both the Boston and New York City Marathons, and a four-time winner of the Los Angeles Marathon.

During her athletics career she was nominated for the Laureus World Sports Awards and Women's Sports Foundation Athlete of the Year.

Peter Van de Vliet, the IPC’s Medical and Scientific Director, said: “On behalf of the IPC I would like to congratulate Cheri on this appointment which is thoroughly deserved.

“Not only is this great news for her but the whole Paralympic Movement, as it underlines our growing profile in world sport.”

In 2004, Blauwet was a winner of the American Association of People with Disabilities Paul Hearne Award, given annually to three emerging leaders nationwide for their potential to change the face of the disability movement.

She is a graduate of Stanford Medical School, and is currently a senior resident in Physical Medicine and Rehabilitation at Spaulding Rehabilitation Hospital, a teaching affiliate of Harvard Medical School.

Since 2010 she has been part of the IPC Medical Committee which has been established to provide recommendations on all policies and operational matters related to the medical care of Paralympic athletes. This includes the review of TUE Applications in accordance with the World Anti-Doping Code and International Standard for TUE, and monitoring the implementation of event-related medical care programmes.